Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Bacterial Infections and Mycoses

Free Subscription 10.11.2025 7 Am J Trop Med Hyg 13 Antimicrob Agents Chemother 2 BMC Pediatr 2 Curr Microbiol 2 Eur J Clin Microbiol Infect Dis 1 Int J Cancer 1 J Antimicrob Chemother 3 J Biol Chem 1 J Infect Dis 1 J Med Microbiol 1 PLoS Med 2 PLoS Negl Trop Dis 7 PLoS One 2 PLoS Pathog 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Trop Med Hyg

1. IZUDI J, Sekaggya-Wiltshire C, Cattamanchi A
   Missed Opportunities in Engaging Community Pharmacies for Integrated Tuberculosis Care in Sub-Saharan Africa: A Call to Action.
   Am J Trop Med Hyg. 2025 Nov 6:tpmd250477. doi: 10.4269/ajtmh.25-0477.
   PubMed         Abstract available
   
   
2. BIELLI VEH, Daoudi S, Collet L, Delmas J, et al
   Angiostrongyliasis in an Infant Presenting as Lymphocytic Meningitis.
   Am J Trop Med Hyg. 2025 Nov 6:tpmd250213. doi: 10.4269/ajtmh.25-0213.
   PubMed         Abstract available
   
   
3. ZSORI M, Taunton C, Pritchett J, Payne D, et al
   Most Patients with Acute Rheumatic Fever in Remote Far North Queensland, Australia, Do Not Present to Healthcare Facilities with a Group A Streptococcus Infection Before Diagnosis.
   Am J Trop Med Hyg. 2025 Nov 4:tpmd250479. doi: 10.4269/ajtmh.25-0479.
   PubMed         Abstract available
   
   
4. ORTIZ FT, Perez CA, Binder LC, Serpa MCA, et al
   Revisiting the Role of Opossums (Marsupialia) as Sentinel for Brazilian Spotted Fever Caused by Rickettsia rickettsii.
   Am J Trop Med Hyg. 2025;113:966-973.
   PubMed         Abstract available
   
   
5. PADDOCK CD, Harris A, Clark TR, Bullock HA, et al
   Rickettsia lanei, sp. nov. (Rickettsiales: Rickettsiaceae), a Newly Recognized Pathogen of Humans Associated with the Rabbit Tick, Haemaphysalis leporispalustris (Acari: Ixodidae).
   Am J Trop Med Hyg. 2025;113:957-965.
   PubMed         Abstract available
   
   
6. RAO G, Barker T, Brunkard J, Brown T, et al
   Evaluation of an Emergency Water Tank Monitoring Program Implemented During Cholera Outbreak in Lusaka, Zambia (2017-2018).
   Am J Trop Med Hyg. 2025;113:974-979.
   PubMed         Abstract available
   
   
7. MCMILLAN IA, Kallas GN, McMillan JKP, Guest LT, et al
   Analysis of Confirmed Leptospirosis Cases in Hawai'i Identifies Spatial and Environmental Patterns of Incidence.
   Am J Trop Med Hyg. 2025;113:980-989.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

8. LODISE TP, Min J, Nathanson BH, Yucel E, et al
   Comparison of early treatment with ceftolozane/tazobactam versus polymyxin-based therapy of pneumonia due to MDR Pseudomonas aeruginosa (PUMA).
   Antimicrob Agents Chemother. 2025;69:e0056925.
   PubMed         Abstract available
   
   
9. WANG C, Feng Y, Zong Z
   Colistin heteroresistance in Enterobacter due to base heterozygosity at certain phoP and phoQ locations.
   Antimicrob Agents Chemother. 2025;69:e0071325.
   PubMed         Abstract available
   
   
10. KUNZ COYNE AJ, Gray R, May E, Curry H, et al
    Molecular and pharmacodynamic insights into beta-lactam therapy for high-inoculum Enterobacter cloacae complex infections.
    Antimicrob Agents Chemother. 2025;69:e0117025.
    PubMed         Abstract available
    
    
11. COJUTTI PG, Pai MP, Gatti M, Rinaldi M, et al
    Targeting Pseudomonas aeruginosa resistance at the exposure frontier: a population PK/PD blueprint for ceftolozane/tazobactam continuous infusion.
    Antimicrob Agents Chemother. 2025;69:e0104225.
    PubMed         Abstract available
    
    
12. POUYA N, Finch NA, Granillo A, Bhimraj A, et al
    Pharmacokinetics of sulbactam-durlobactam in patients with Acinetobacter baumannii ventriculitis: a report of two cases.
    Antimicrob Agents Chemother. 2025;69:e0067425.
    PubMed         Abstract available
    
    
13. AOKI W, Uwamino Y, Kubota H, Kamoshita Y, et al
    Evaluation of in vitro efficacy of aztreonam-nacubactam and cefepime-nacubactam against clinical isolates of Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2025;69:e0075525.
    PubMed         Abstract available
    
    
14. ZENG Q, Huang H, Lu J, Wu L, et al
    Comparison of different colistin sulfate regimens for carbapenem-resistant gram-negative bacteria pneumonia in neurocritical care patients: a retrospective cohort study.
    Antimicrob Agents Chemother. 2025 Sep 22:e0064425. doi: 10.1128/aac.00644.
    PubMed         Abstract available
    
    
15. WIEDERHOLD NP
    Case Commentary: Successful use of olorofim for the treatment of multi-drug-resistant Lomentospora prolificans infection in a child.
    Antimicrob Agents Chemother. 2025;69:e0107225.
    PubMed         Abstract available
    
    
16. ALSHIRAIHI IM, Lam H, Troyer BT, Tran KN, et al
    Characterization of new mouse models of acute and chronic Mycobacterium abscessus infection for antimicrobial drug screening.
    Antimicrob Agents Chemother. 2025;69:e0047525.
    PubMed         Abstract available
    
    
17. KOCER K, My TN, Sy BT, Gopel L, et al
    Efficacy of cefiderocol in combination with xeruborbactam versus taniborbactam against cefiderocol-resistant NDM-producing Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2025;69:e0085725.
    PubMed         Abstract available
    
    
18. MOHAMAD M, Hurst MM, Elkrewi E, Randall CP, et al
    Nature of bacitracin resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2025 Nov 4:e0087525. doi: 10.1128/aac.00875.
    PubMed         Abstract available
    
    
19. CHEN B, Chen Y, Chen M, Mao Y, et al
    Population pharmacokinetics and Monte Carlo-based dosing optimization of trimethoprim-sulfamethoxazole.
    Antimicrob Agents Chemother. 2025;69:e0051925.
    PubMed         Abstract available
    
    
20. FORTINI M, Jones TW, Grams TR, Mehra S, et al
    Successful use of olorofim for the treatment of Lomentospora prolificans knee tendonitis, synovitis, and concomitant osteomyelitis in an immunocompetent child.
    Antimicrob Agents Chemother. 2025;69:e0060225.
    PubMed         Abstract available
    
    

    
    BMC Pediatr

21. ZHANG M, Zhu X, Lu X, Jiang L, et al
    Rickettsia felis meningoencephalitis in a 10-year-old child: a case report and literature review.
    BMC Pediatr. 2025;25:901.
    PubMed         Abstract available
    
    
22. LUO H, Wu P, Yang H, Zhang B, et al
    Clinical analysis of Pneumocystis jirovecii pneumonia in children with malignant disease.
    BMC Pediatr. 2025;25:906.
    PubMed         Abstract available
    
    

    
    Curr Microbiol

23. RANI P, Kumar S
    A Proteomic View on Persistence of Yersinia pestis in Tap Water Microcosm.
    Curr Microbiol. 2025;82:598.
    PubMed         Abstract available
    
    
24. NANDLAL SC, Pustam A, Nagassar RP, Jayaraman J, et al
    Analysis of Clinical Gram-Negative Carbapenem Resistant Acinetobacter baumannii and Klebsiella pneumoniae Isolates from Wounds of Patients at a Hospital Reveals Complex Resistome and the First Report of bla(SPM) and bla(SME) Genes in Trinidad, West In
    Curr Microbiol. 2025;83:1.
    PubMed         Abstract available
    
    

    
    Eur J Clin Microbiol Infect Dis

25. ZIMMERMANN V, Fourre N, Senn L, Guery B, et al
    Short course of antimicrobial treatment for uncomplicated enterococcal bacteremia.
    Eur J Clin Microbiol Infect Dis. 2025 Nov 7. doi: 10.1007/s10096-025-05348.
    PubMed         Abstract available
    
    
26. TOOROP MMA, Kraakman MEM, Claas ECJ, Wessels E, et al
    Discovery of IS1515 transposition into the Spn9802 fragment of Streptococcus pneumoniae and its implications for PCR-based diagnostic assays.
    Eur J Clin Microbiol Infect Dis. 2025 Nov 2. doi: 10.1007/s10096-025-05328.
    PubMed         Abstract available
    
    

    
    Int J Cancer

27. TAHER YY, Lehmann L, Zamzam M, Mona Atteya H, et al
    Risk factors and clinical implications of hyperglycemia during induction therapy in pediatric acute lymphoblastic leukemia.
    Int J Cancer. 2026;158:163-171.
    PubMed         Abstract available
    
    

    
    J Antimicrob Chemother

28. BOYD SE, Wootton M, Howe RA, Livermore DM, et al
    Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'.
    J Antimicrob Chemother. 2025 Nov 3:dkaf392. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Biol Chem

29. AGARWAL R, Biswas K, Agrawal A, Shankar NN, et al
    SA-XV, a 15-amino acid fragment of host defense peptide S100A12, targets mitochondria and is protective against fungal infections.
    J Biol Chem. 2025;301:110743.
    PubMed         Abstract available
    
    
30. LIU J, Zhang X, Zhang K, Wang J, et al
    Structure-based identification of salvianolic acid B as an inhibitor targeting Salmonella InvC ATPase.
    J Biol Chem. 2025;301:110722.
    PubMed         Abstract available
    
    
31. KADOOKA C, Tanaka Y, Sato K, Sato H, et al
    Cgm1 is a beta-galactoside alpha-(1 --> 4)-mannosyltransferase involved in the biosynthesis of capsular glucuronoxylomannogalactan in Cryptococcus neoformans.
    J Biol Chem. 2025;301:110632.
    PubMed         Abstract available
    
    

    
    J Infect Dis

32. JIANG JH, Lim CX, Lai X, Kostoulias X, et al
    Daptomycin-Loaded Nanocarriers Facilitate Synergistic Killing of Methicillin-Resistant Staphylococcus aureus via Lipid-Mediated Interactions and Targeting.
    J Infect Dis. 2025 Nov 4:jiaf492. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Microbiol

33. HUYNH T, Lam T, Pham N, Luong L, et al
    Mathematical modelling of synergistic triple-antibiotic therapy against carbapenem-resistant Acinetobacter baumannii at clinically achievable concentrations.
    J Med Microbiol. 2025;74.
    PubMed         Abstract available
    
    

    
    PLoS Med

34. WATERLOW NR, Chandler CIR, Cooper BS, Moore CE, et al
    Combining demographic shifts with age-based resistance prevalence to estimate future antimicrobial resistance burden in Europe and implications for targets: A modelling study.
    PLoS Med. 2025;22:e1004579.
    PubMed         Abstract available
    
    

    
    PLoS Negl Trop Dis

35. GAO Y, Wang Y, Du L, Liu X, et al
    Human infection with Candidatus Rickettsia jingxinensis: First identification and clinical characteristics.
    PLoS Negl Trop Dis. 2025;19:e0013685.
    PubMed         Abstract available
    
    
36. PENG PY, Xu L, Sun JQ, Yan TL, et al
    Epidemiologic features and potential year of life lost of scrub typhus in China: A nationwide surveillance analysis (2006- 2023).
    PLoS Negl Trop Dis. 2025;19:e0013666.
    PubMed         Abstract available
    
    

    
    PLoS One

37. LI C, Zhu Y, Qi X, Chai Z, et al
    Design of a multi-epitope recombinant BCG vaccine targeting Brucella OMP31, LptE and VirB2 in immunoinformatics approaches.
    PLoS One. 2025;20:e0334843.
    PubMed         Abstract available
    
    
38. KANG MW, Ahn SY, Kang Y
    Impact of blood culture positivity at intensive care unit admission on mortality in infective endocarditis: Machine learning and deep learning-based causal inference models.
    PLoS One. 2025;20:e0333351.
    PubMed         Abstract available
    
    
39. KIM A, Kim HW, Kim JS, Kim JW, et al
    Depressive episode and treatment outcomes in elderly individuals with tuberculosis: A prospective cohort study in Korea.
    PLoS One. 2025;20:e0335897.
    PubMed         Abstract available
    
    
40. ZHANG T, Meng X, Wang X, Mi S, et al
    Associations of serum pepsinogen and Gastrin-17 with Helicobacter pylori infection, sex, and age, in an asymptomatic coastal population: A cross-sectional study in Rizhao, China.
    PLoS One. 2025;20:e0335228.
    PubMed         Abstract available
    
    
41. ALOSSAIMI MA, Abdel Bar FM, Elekhnawy E, ElNaggar MH, et al
    Antibacterial and antiviral potential of harmalacidine hydrochloride, a beta-carboline alkaloid, against respiratory tract pathogens: Staphylococcus aureus and H1N1 influenza virus.
    PLoS One. 2025;20:e0335014.
    PubMed         Abstract available
    
    
42. LIAO C, Peng J, Luo S, Xie X, et al
    Antimicrobial multidrug resistance of Escherichia coli from broiler farms in Zhanjiang, China.
    PLoS One. 2025;20:e0335518.
    PubMed         Abstract available
    
    
43. KOSTRZEWA M, Sadat Seyyedsalehi M, Godono A, Collatuzzo G, et al
    Cancer Prevention at Work (CPW) project: Rationale, framework and research protocol.
    PLoS One. 2025;20:e0335752.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

44. HORNER EM, Lachmayer V, Hermanns T, Moldovan A, et al
    Identification and characterization of a ubiquitin E3 RING ligase of the Chlamydia-like bacterium Simkania negevensis.
    PLoS Pathog. 2025;21:e1013626.
    PubMed         Abstract available
    
    
45. MIKI T, Yamaguchi H, Kobayashi M, Ito M, et al
    RegIIIbeta promotes Salmonella Typhimurium colonization of the gut in the early-stage gastrointestinal infection by enhancing flagella-driven locomotion.
    PLoS Pathog. 2025;21:e1013665.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

46. TATARA AM, Lightbown S, Kang S, Jung WH, et al
    Scaffold vaccination for prevention of orthopedic device infection.
    Proc Natl Acad Sci U S A. 2025;122:e2409562122.
    PubMed         Abstract available
    
    
47. SONG C, Sun L, Wang J, Liu S, et al
    ENKD1 attenuates antibacterial immunity by facilitating TRIM21-mediated RUBCN degradation to suppress LC3-associated phagocytosis.
    Proc Natl Acad Sci U S A. 2025;122:e2501953122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.